Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1990 1
1991 1
1993 1
1995 1
1996 4
1997 3
1998 1
2002 1
2003 2
2004 3
2005 2
2006 2
2007 2
2009 2
2010 1
2011 1
2012 2
2013 7
2014 3
2015 2
2016 1
2017 1
2019 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Results by year
Filters applied: . Clear all
Page 1
Retraction: PM02734 (elisidepsin) induces caspase-independent cell death associated with features of autophagy, inhibition of the Akt/mTOR signaling pathway, and activation of death-associated protein kinase.
Ling YH, Aracil M, Zou Y, Yuan Z, Lu B, Jimeno J, Cuervo AM, Perez-Soler R. Ling YH, et al. Among authors: aracil m. Clin Cancer Res. 2013 Sep 1;19(17):4900. doi: 10.1158/1078-0432.CCR-13-1910. Clin Cancer Res. 2013. PMID: 24003061 Free article. No abstract available.
Trabectedin as a chemotherapy option for patients with BRCA deficiency.
Monk BJ, Lorusso D, Italiano A, Kaye SB, Aracil M, Tanović A, D'Incalci M. Monk BJ, et al. Among authors: aracil m. Cancer Treat Rev. 2016 Nov;50:175-182. doi: 10.1016/j.ctrv.2016.09.009. Epub 2016 Sep 15. Cancer Treat Rev. 2016. PMID: 27710871 Review.
Trabectedin Reveals a Strategy of Immunomodulation in Chronic Lymphocytic Leukemia.
Banerjee P, Zhang R, Ivan C, Galletti G, Clise-Dwyer K, Barbaglio F, Scarfò L, Aracil M, Klein C, Wierda W, Plunkett W, Caligaris-Cappio F, Gandhi V, Keating MJ, Bertilaccio MTS. Banerjee P, et al. Among authors: aracil m. Cancer Immunol Res. 2019 Dec;7(12):2036-2051. doi: 10.1158/2326-6066.CIR-19-0152. Epub 2019 Sep 17. Cancer Immunol Res. 2019. PMID: 31530560 Free PMC article.
Levels of p27(kip1) determine Aplidin sensitivity.
Moneo V, Serelde BG, Leal JF, Blanco-Aparicio C, Diaz-Uriarte R, Aracil M, Tercero JC, Jimeno J, Carnero A. Moneo V, et al. Among authors: aracil m. Mol Cancer Ther. 2007 Apr;6(4):1310-6. doi: 10.1158/1535-7163.MCT-06-0729. Mol Cancer Ther. 2007. PMID: 17431109 Free article.
Lurbinectedin versus pegylated liposomal doxorubicin or topotecan in patients with platinum-resistant ovarian cancer: A multicenter, randomized, controlled, open-label phase 3 study (CORAIL).
Gaillard S, Oaknin A, Ray-Coquard I, Vergote I, Scambia G, Colombo N, Fernandez C, Alfaro V, Kahatt C, Nieto A, Zeaiter A, Aracil M, Vidal L, Pardo-Burdalo B, Papai Z, Kristeleit R, O'Malley DM, Benjamin I, Pautier P, Lorusso D. Gaillard S, et al. Among authors: aracil m. Gynecol Oncol. 2021 Nov;163(2):237-245. doi: 10.1016/j.ygyno.2021.08.032. Epub 2021 Sep 11. Gynecol Oncol. 2021. PMID: 34521554 Clinical Trial.
Marine compounds inhibit growth of multiple myeloma in vitro and in vivo.
Steiner N, Ribatti D, Willenbacher W, Jöhrer K, Kern J, Marinaccio C, Aracil M, García-Fernández LF, Gastl G, Untergasser G, Gunsilius E. Steiner N, et al. Among authors: aracil m. Oncotarget. 2015 Apr 10;6(10):8200-9. doi: 10.18632/oncotarget.3362. Oncotarget. 2015. PMID: 25860931 Free PMC article.
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin.
Ordóñez JL, Amaral AT, Carcaboso AM, Herrero-Martín D, del Carmen García-Macías M, Sevillano V, Alonso D, Pascual-Pasto G, San-Segundo L, Vila-Ubach M, Rodrigues T, Fraile S, Teodosio C, Mayo-Iscar A, Aracil M, Galmarini CM, Tirado OM, Mora J, de Álava E. Ordóñez JL, et al. Among authors: aracil m. Oncotarget. 2015 Aug 7;6(22):18875-90. doi: 10.18632/oncotarget.4303. Oncotarget. 2015. PMID: 26056084 Free PMC article.
Paneth cells are also target of the ribotoxic lectin nigrin b.
Jiménez P, Gayoso MJ, Garrosa M, Córdoba-Díaz D, Cabrero P, Tejero J, Aracil M, Girbés T. Jiménez P, et al. Among authors: aracil m. Histol Histopathol. 2014 Aug;29(8):1057-63. doi: 10.14670/HH-29.1057. Epub 2014 Feb 24. Histol Histopathol. 2014. PMID: 24563426
Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin.
Ordóñez JL, Amaral AT, Carcaboso AM, Herrero-Martín D, García-Macías MDC, Sevillano V, Alonso D, Pascual-Pasto G, San-Segundo L, Vila-Ubach M, Rodrigues T, Fraile S, Teodosio C, Mayo-Iscar A, Aracil M, Galmarini CM, Tirado OM, Mora J, de Álava E. Ordóñez JL, et al. Among authors: aracil m. Oncotarget. 2017 Jun 27;8(26):43592. doi: 10.18632/oncotarget.18610. Oncotarget. 2017. PMID: 28672777 Free PMC article. No abstract available.
46 results